LSC Recent Webinars on BIO

  1. Accelerating CHO Media Development: From Screening To AI Design 10/1/2026

    Discover how high-throughput screening, process analytics, and AI-guided modeling can help identify promising CHO media and feed combinations faster and support a more predictive approach.

  2. Lessons In Building Connected Lab Operations Across Development And GMP 9/30/2026

    Building connected operations across development and GMP environments removes bottlenecks and ensures data integrity. Explore practical insights to scale and standardize your lab workflows.

  3. Evaluating Modular CAR T Manufacturing Workflows 9/28/2026

    As CAR T manufacturing scales, balancing throughput, flexibility, and cell quality becomes increasingly complex. Explore strategies for improving process control, reducing bottlenecks, and more.

  4. Scaling Cell And Gene Therapy Manufacturing 9/25/2026

    Artificial intelligence is reshaping healthcare. Discover proven strategies for secure, compliant AI adoption, strong data governance, and seamless integration to improve patient outcomes.

  5. IND In As Little As 6 Months: Now Beyond mAbs - Accelerating Bispecifics, Fc-Fusions And High-Concentration Biologics To The Clinic 9/25/2026

    Listen as our experts outline expanded accelerated DNA-to-IND pathways for a broader range of biologic modalities, examining how expression technologies and integrated CMC strategies can shorten development timelines.

  6. How Sodium Hydroxide CIP Affects Column Performance And Resin Lifetime 9/24/2026

    Sodium hydroxide CIP is essential for column hygiene, but cleaning decisions carry real tradeoffs for resin longevity and long-term chromatography performance.

  7. Annex 1 In Practice: Turning CCS Into Cleanroom Design 9/24/2026

    Learn how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.

  8. De-Risking The Path To GMP Manufacturing At Another Organization 9/23/2026

    Successful tech transfer depends on more than moving a process. Early alignment across process readiness, analytical strategy, governance, and decision-making helps reduce execution risk.

  9. Challenges And Opportunities For MSC Expansion Workflows 9/22/2026

    Discover how optimizing cell culture platforms and closed systems reduces manufacturing costs, improves media efficiency, and supports scalable stem cell production.

  10. Improving Scale-Up Starts With Expression Strategy 9/21/2026

    Early expression screening and strain-engineering strategies can reveal manufacturing risks and clarify which recombinant protein candidates are worth advancing before major investments are made.